Skip to content

Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health

Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health Amongst Older Women With High Fracture Risk: A Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05721014
Enrollment
194
Registered
2023-02-09
Start date
2021-10-04
Completion date
2024-02-14
Last updated
2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Density, Low, Bone Loss, Osteopenia, Osteoporosis

Keywords

osteoporosis, osteopenia, bone mineral density, bone density, physical activity, strength training, isometric training

Brief summary

The aim of this clinical trial is to investigate the effect of the OsteoStrong training method and the Individually Adapted and Combined Training on the bone health of older women with high fracture risk. Additionally, the aim is also to explore the participants' experiences of each training method. Participants will be randomised to either treatment arm A (OsteoStrong) or treatment arm B (Individually Adapted and Combined Training). Participants in both groups will train for nine months. Treatment arm A will train individually once a week and treatment arm B will train in a group twice a week. Both groups will have a training instructor who will supervise and give training instructions. Researchers will compare the groups to see the effects of the training methods on the participants' bone health among other outcome measures. The participants will be tested at baseline and post-intervention (9 months later).

Interventions

OTHEROsteoStrong

This training method is an isometric high-impact loading in four different training machines (Spectrum) and balance training on a vibration plate. The four machines are chest press, leg press, pull-down and deadlift. The participants press and/or pull isometrically for around 10-15 seconds 1-3 times on every machine. The training session takes around 20 minutes and is performed individually by the participants with the help of a training instructor.

OTHERIndividually Adapted and Combined Physical Training

This training method is based on the current recommendations on physical activity for people with osteoporosis. The training is divided into two training sessions: Circuit training with ten stations with different exercises for the whole body (strength, balance, endurance, weight-bearing). The participants spend 40 seconds on each station. This is repeated during 40 minutes. The training session starts with a joint warm-up and ends with a cool-down. Strength training with machines for the whole body with the intensity of up to 70-80 % of one repetition max (1RM). The training session starts with a joint warm-up and and a voluntary individual cool-down. The training session takes around 60 minutes and is performed in a group with the help of a training instructor. The participants also have the option to do a home based exercise programme that they could do in a few cases when they were unable to attend the physical group training.

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
The Swedish School of Sport and Health Sciences
CollaboratorOTHER
Linkoeping University
CollaboratorOTHER_GOV
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
65 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

* Woman, 65-79 years old. * Vaccinated against Covid-19. * Be able to participate in nine months of training. * Untreated with Osteoporosis-medications, or have an ongoing treatment since at least one year back.

Exclusion criteria

* Ongoing treatment with Osteoporosis-medications with an onset within a year, or a previous treatment which was terminated within the last five years. * Ongoing treatment with Osteoporosis-medications that has been delayed for more than eight months for Denosumab, or more than 18 months for bisphosphonates. * Vertebral fracture, that have been diagnosed within three months. * Vertebral fracture or hip fracture, that have not previously been treated with Osteoporosis-medications or been assessed by a physician. * Bilateral hip replacements. * Symptomatic disc herniation, inguinal herniation or umbilical herniation. * Untreated hypertension. * Other diseases that can affect the results and participation in the study: malignant diseases, muscle dystrophy, secondary osteoporosis, or other conditions that would hinder study participation. * Ongoing treatment with oral cortisone pills (≥ 5 mg Prednisolone). * Conditions that hinders the conduction of impact microindentation with OsteoProbe: large edema, skin infection, allergy towards local anaesthetics. * Ongoing or previous training (within the last year) at OsteoStrong.

Design outcomes

Primary

MeasureTime frameDescription
Bone Material Strength Index (BMSI)Change from baseline at 9 monthsBone Material Strength Index measured with impact microindentation using OsteoProbe

Secondary

MeasureTime frameDescription
One leg standing (eyes closed)Change from baseline at 9 monthsBalance test
Two leg standing on a straight line (eyes open)Change from baseline at 9 monthsBalance test
Static sit-upChange from baseline at 9 monthsSitting with the upper body in 45 degrees
Lung capacityChange from baseline at 9 monthsLung capacity measured with dynamic spirometry (Welch Allyn)
Bone Mineral Density (BMD)Change from baseline at 9 monthsBone Mineral Density and T-score measured with Dual-Energy X-ray Absorptiometry (DXA)
Procollagen Type 1 N-terminal propeptide (S-PINP)Change from baseline at 3 and 9 monthsBone biomarker
Serum C-telopeptide cross-link type 1 collagen (S-CTX)Change from baseline at 3 and 9 monthsBone biomarker
SclerostinChange from baseline at 3 and 9 monthsBone biomarker
Bone alkaline phosphatase (S-BALP)Change from baseline at 3 and 9 monthsBone biomarker
Self-rated health questionnaire (SF-36)Change from baseline at 9 monthsA questionnaire with multiple choice questions about general health
Falls Efficacy Scale (FES)Change from baseline at 9 monthsA questionnaire about self-efficacy and fear of falling, 1-10, where 0 equals not sure at all and 10 equals completely sure. Higher scores equals better outcome.
One leg standing (eyes open)Change from baseline at 9 monthsBalance test
Numerical Rating Scale (NRS)Change from baseline at 3 and 9 monthsA pain rating scale from 0-10, where 0 equals no pain and 10 equals maximum/worst possible pain imaginable. Higher scores equals worse outcome.
Back extension strengthChange from baseline at 9 monthsMeasuring back extension strength with Digimax
Grip strengthChange from baseline at 9 monthsMeasuring grip strength with hand dynamometer (JAMAR)
Chair stand testChange from baseline at 9 months5 seconds, 30 seconds and time for making 50 chair stands
Back extension enduranceChange from baseline at 9 monthsMeasuring back extension endurance with Sörensen's test
Two leg standing on a straight line (eyes closed)Change from baseline at 9 monthsBalance test
Walking forward on a straight lineChange from baseline at 9 monthsBalance test
Walking backwards between to linesChange from baseline at 9 monthsBalance test
BtrackSChange from baseline at 9 monthsBalance test, measuring body sway, standing on a platform with both legs together, arms crossed and eyes closed.
AccelerometryChange from baseline at 9 monthsAccelerometers worn around the waist to measure physical activity levels for up to nine days.
Socialstyrelsens questionnaire for lifestyle habitsChange from baseline at 9 monthsA questionnaire with multiple choice questions about falls and fractures, physical activity, sitting, alcohol and smoking

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026